Rosa Guerra, MD
Gynecologic Oncology · Houston, TXNPI 1871912782
Payments from drug & device makers
Across 43 payments — averaging $95.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- Medtronic$1K
- Immunogen, Inc.$133
- Eisai Inc.$128
- GSK$119
- Genmab U.S., Inc.$102
- plus $425 from 6 others
What the payments were for
- Travel & lodging$1,91447%
- Food & beverage$2,01249%
- Education$1614%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $2,065 |
| Medtronic | 14 | $1,115 |
| Immunogen, Inc. | 1 | $133 |
| Eisai Inc. | 4 | $128 |
| GSK | 2 | $119 |
| Genmab U.S., Inc. | 4 | $102 |
| Merck | 4 | $100 |
| Seagen Inc. | 1 | $99 |
| Foundation Medicine, Inc. | 1 | $98 |
| Davol Inc. | 1 | $69 |
| Coopersurgical, Inc. | 1 | $37 |
| Evofem Biosciences, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,972
- HYSTEROLUX FLUID MANAGEMENT SYSTEM CONTROL UNIT$659
- V-LOC 180$134
- Elahere$133
- LigaSure$103
How this compares
$4,087 in reported general payments places this provider in the 50th percentile of 135 gynecologic oncology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 24 | $1,300 |
| Prochlorperazine Maleate | 21 | $581 |
| Oxycodone Hcl | 59 | $466 |
| Letrozole | 14 | $320 |
| Gabapentin | 27 | $190 |
| Ibuprofen | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Houston
- Pamela SolimanHouston$30.7M
- Robert ColemanHouston$3.4M
- Michael FrumovitzHouston$1M
- Joseph LucciHouston$292K
- David GershensonHouston$273K
- Anuj SuriHouston$250K
- Aparna KamatHouston$208K
- Maurie MarkmanHouston$204K
- Anil SoodHouston$187K
- Larissa MeyerHouston$146K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.